Skip to main content

Table 3 Morbidity rate, cost difference between patients with and without complications, and expected savings per patient receiving goal-directed fluid therapy (GDFT)

From: Potential return on investment for implementation of perioperative goal-directed fluid therapy in major surgery: a nationwide database study

Surgery

Morbidity rate, %

Cost difference between patients with and without complications, dollar

Potential savings per patient with GDFT, dollara

All

37.5

11,824

754–1286

AAA open repair

64.9

23,383

2580–4401

Vascular bypass

26.3

15,130

676–1154

Esophagectomy

67.7

30,542

3515–5996

Gastrectomy

20.2

15,153

520–888

Colectomy

43.3

13,096

964–1644

Resection of rectum

33.6

10,937

625–1066

Hepatectomy

34.3

17,043

994–1695

Pancreatectomy

47.5

23,071

1863–3178

Cystectomy

58.9

15,150

1517–2588

F&H fracture repair

38.5

5413

354–604

  1. AAA abdominal aortic aneurysm, F&H femur and hip
  2. aFor patients with valid cost data, unadjusted